Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-01-28

FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves a supplemental application for hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc. (generic) under an Abbreviated New Drug Application pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

SUPPL AP for HYDRALAZINE HYDROCHLORIDE (HYDRALAZINE HYDROCHLORIDE)